Corneal Deformation Response and Ocular Geometry: A Noninvasive Diagnostic Strategy in Marfan Syndrome

LAUREN C. BEENE, ELIAS I. TRABOULSI, IBRAHIM SEVEN, MATTHEW R. FORD, ABHIJIT SINHA ROY, ROBERT S. BUTLER, AND WILLIAM J. DUPPS, JR

PURPOSE: To evaluate corneal air-puff deformation syndrome, including increased deformation, decreased responses and ocular geometry as predictors of Marfan bending resistance, and decreased energy dissipation syndrome. capacity. A predictive model incorporating HLA and DESIGN: Prospective observational clinical study. corneal curvature shows greatest potential for noninva- METHODS: Sixteen investigator-derived, 4 standard sive clinical diagnosis of Marfan syndrome. (Am J Ocular Response Analyzer (ORA), and geometric vari- Ophthalmol 2016;161:56–64. Ó 2016 by Elsevier Inc. ables from corneal tomography and optical biometry using All rights reserved.) Oculus Pentacam and IOL Master were assessed for discriminative value in Marfan syndrome, measuring right eyes of 24 control and 13 Marfan syndrome sub- ARFAN SYNDROME IS AN AUTOSOMAL DOMI- jects. Area under the receiver operating characteristic nant connective tissue disorder caused by muta- 1 (AUROC) curve was assessed in univariate and multivar- M tions in FBN1. Clinical diagnosis currently iate analyses. conforms to the Ghent criteria, most recently revised in 2 RESULTS: Six investigator-derived ORA variables suc- 2010. These diagnostic criteria have evolved since the cessfully discriminated Marfan syndrome. The best lone original description by Antoine-Bernard Marfan in 1896, disease predictor was Concavity Min (Marfan syndrome reflecting challenges presented by a broad phenotypic spec- 47.5 ± 20, control 69 ± 14, P [ .003; AUROC [ trum and the age-dependent nature of individual abnor- 0.80). Corneal hysteresis (CH) and corneal resistance malities, as well as advances in our understanding of the factor (CRF) were decreased (Marfan syndrome CH genetic etiology of Marfan syndrome and differentiation 2–6 9.45 ± 1.62, control CH 11.24 ± 1.21, P [ .01; Marfan from related conditions. Early diagnosis is of crucial syndrome CRF 9.77 ± 1.65, control CRF 11.03 ± 1.72, importance in Marfan syndrome owing to the life- P [ .01) and corneas were flatter in Marfan syndrome threatening sequelae of cardiac and vascular pathology. (Marfan syndrome Kmean 41.25 ± 2.09 diopter, control While the estimated prevalence of Marfan syndrome has Kmean 42.70 ± 1.81 diopter, P [ .046). No significant been cited at 2–3 in 10 000, an exact prevalence is difficult differences were observed in central corneal thickness, to measure owing to presumed underdiagnosis of this 7,8 axial eye length, or intraocular pressure. A multivariate condition. regression model incorporating corneal curvature and The role of the ocular examination in diagnosing Marfan hysteresis loop area (HLA) provided the best predictive syndrome has gained prominence with the revised Ghent value for Marfan syndrome (AUROC [ 0.85). criteria, as the presence of ectopia lentis with aortic dila- >_ 2 CONCLUSIONS: This study describes novel biodynamic tion (Z-score 2) is currently sufficient for diagnosis. How- features of corneal deformation responses in Marfan ever, the only other ocular feature officially considered in diagnosis is myopia greater than 3 diopters (D), which has questionable specificity for this condition.2 The poten- Accepted for publication Sep 22, 2015. tial for ocular abnormalities to aid in diagnosis may be From the Case Western Reserve University School of Medicine (L.C.B.); the Center for Genetic Eye Diseases (L.C.B., E.I.T.) and much greater than currently acknowledged, as fibrillin-1 Ocular Biomechanics & Imaging Laboratory (I.S., M.R.F., A.S.R., microfibrils that are abnormally formed owing to the W.J.D.), Cole Eye Institute, Clinic Foundation; the disease-causing mutations in FBN1 are widely distributed Department of Biomedical Engineering, Case Western Reserve 9 University (M.R.F., W.J.D.); and Quantitative Health Sciences (R.S.B.) in the human eye. Histologic study of fibrillin-1 microfi- and the Department of Biomedical Engineering (W.J.D.), Cleveland brils in the Marfan syndrome eye found differences in Clinic Lerner Research Institute, Cleveland, Ohio. both quantity and quality of microfibrils, and it is possible Lauren Beene is now affiliated with Rainbow Babies & Children’s Hos- pital, University Hospitals Case Medical Center, Cleveland, Ohio. Abhi- that the impact of their malformation likely leads to global 10,11 jit Sinha Roy is now affiliated with Biomechanics and Mathematical ocular changes. Modeling Solutions Lab, Narayana Nethralaya, Bangalore, India. Investigation of biomechanical and dynamic changes in Inquiries to William J. Dupps, Jr, Cole Eye Institute, , 9500 Euclid Ave/i-32, Cleveland, OH 44195; e-mail: bjdupps@sbcglobal. tissues that contain abnormal fibrillin-1 is a reasonable net next step in refining the approach to diagnosing Marfan

56 Ó 2016 BY ELSEVIER INC.ALL RIGHTS RESERVED. 0002-9394/$36.00 http://dx.doi.org/10.1016/j.ajo.2015.09.027 syndrome. Abnormalities in corneal biomechanical prop- of Marfan syndrome per the 1996 or 2010 Ghent criteria, erties, or, more precisely, behavior as measured by the tech- based on clinical examinations from ophthalmology, cardi- niques used in the present study, have been detected in a ology, and medical genetics, and were all established pa- variety of corneal disorders and postoperative conditions, tients from the Cole Eye Institute, Cleveland Clinic or including Fuchs dystrophy,12 post–laser in situ keratomil- the University Hospitals Case Medical Center. Partici- eusis (LASIK) eyes,12,13 and keratoconus,12,14–16 a disease pants were evaluated between October 2012 and July characterized by stromal degeneration and disruption of 2013. Individuals who had undergone any kind of ocular Bowman membrane, of which fibrillin-1 is a component.9 surgery or who only had a suspected diagnosis of Marfan Differences between normal and Marfan syndrome corneas syndrome were excluded from this study. The second group have been previously observed at the microscopic and clin- included healthy age-matched volunteers without history of ical levels. Specifically, Iordanidou and associates evalu- Marfan syndrome or other connective tissue diseases or con- ated Marfan syndrome corneas using confocal microscopy ditions that could affect the health and shape of the cornea, and found highly reflective interconnected lines between such as keratoconus. In total, 13 right eyes of participants keratocytes in the extracellular matrix of over half of with a confirmed diagnosis of Marfan syndrome and 24 right Marfan syndrome corneas, and brightly reflective particles eyes of age-matched controls were evaluated in this study. in the endothelium in Marfan syndrome corneas exclu- 17 sively. Additionally, clinical differences in corneal curva- MEASUREMENTS: The ORA (Reichert Ophthalmic In- ture have been observed repeatedly, as numerous studies struments, Buffalo, New York, USA) assesses corneal have found the Marfan syndrome cornea to be flatter biomechanical behavior through measurement of corneal than non–Marfan syndrome corneas.18–21 Based on these hysteresis (CH) and other features of the corneal deforma- many observations of differences in the Marfan syndrome tion response. Hysteresis is a measurement of the energy cornea, it is reasonable to suspect that corneal absorptive capacity of viscoelastic tissues that undergo deformation responses in Marfan syndrome may also be time-dependent strain upon deformation. The ORA mea- altered.20 sures corneal hysteresis through application of a variable Biomechanical behaviors of the cornea can be assessed air impulse to the central cornea with simultaneous moni- in vivo using the Ocular Response Analyzer (ORA). To toring of the magnitude of corneal deformation using an date, only 1 study has investigated the biomechanical infrared electro-optical collimation detector system.12 behavior in the corneas of individuals with Marfan syn- The pressure and deformation data can be exported for drome.22 Here we expand on the investigation of alter- custom analysis. An illustrative example is provided in ations in biomechanical behavior in corneas of the Figure, with the solid line depicting the pressure individuals with Marfan syndrome, using investigator- applied to the cornea and the dotted line representing derived ORA variables described by Hallahan and associ- corneal deformation. The intensity of photons reflected ates and found to have high predictive value for detecting off the cornea is greatest when the corneal surface is rela- keratoconus.16 We assess the capacity of the corneal defor- tively planar, which occurs at relative applanation. The mation responses to predict a diagnosis of Marfan syndrome cornea passes through 2 points of applanation as it indents both independently and in conjunction with geometric and regains shape. The ORA measures corneal hysteresis as measurements of the Marfan cornea, including corneal cur- the difference in external pressure at these 2 points of vature, central corneal thickness, and axial eye length. applanation, P1 and P2.12 Through this investigation, we explore the possibility of a The ORA also measures the corneal resistance factor novel diagnostic algorithm that may be clinically useful (CRF), which is related to the same pressure values from which in diagnosing future cases of Marfan syndrome. corneal hysteresis is derived. CRF is biased toward the pressure required to achieve applanation during inward deformation of the cornea owing to its definition by (P1 [kP2]). The con- stant k was set empirically by the manufacturer to 0.7 to in- METHODS crease association with central corneal thickness.12 The ORA also provides 2 measurements of intraocular pressure, STUDY DESIGN: This prospective, observational clinical Goldmann-correlated and corneal-compensated IOP, both study followed the tenets of the Declaration of Helsinki and of which are included as basic measurements in this study. complied with the Health Insurance Portability and The 16 investigator-derived variables included in this Accountability Act. The project was prospectively study were previously described in detail.16 The variables approved by the Institutional Review Board of the Cleve- were derived from specific aspects of the ORA waveform land Clinic. Participants were evaluated between and are grouped accordingly. These groups include vari- September 2012 and June 2013 and provided informed ables derived from applanation signal intensity (A1, A2, consent for the study. Applanation Peak Difference, Concavity Min, Concavity Two groups of participants were included in this study. Mean), applied pressure (CRF, CH, P1, P2, P1P2Avg, One group included individuals with a confirmed diagnosis Pmax), and response time (Concavity Duration, Concavity

VOL. 161 CORNEAL DEFORMATION RESPONSE AND GEOMETRY IN MARFAN SYNDROME 57 FIGURE. Graphical representation of selected Ocular Response Analyzer (ORA) signal output. The solid line depicts the pressure applied to the cornea and the dotted line depicts the reflection of infrared light off the cornea surface. Variables are derived from aspects of the standard ORA waveform as shown here. A1 [ peak intensity at first applanation event; A2 [ peak intensity at second applanation event; Pmax [ peak pressure applied, CH [ corneal hysteresis.

Time, Lag Time). Variables were also derived from combi- lated the area under the receiver operating characteristic nations of these properties, including applanation signal in- (AUROC) curve for each variable and tested for significant tensity as a function of response time (Slope Down, Slope differences in their predictive ability to correctly classify Up), pressure and applanation signal intensity (hysteresis Marfan syndrome patients. These tests indicated that no loop area [HLA]), and pressure and time (Impulse). The one variable was better than any of the others in this regard. relationship of many of these variables to the ORA wave- We then generated multivariable models and tested the form is depicted in the Figure. models for improvement in predictive ability relative to Measurements of ocular geometry were obtained in all the simple univariate models. The 23 variables were first patients at the same visit as ORA measurements and tested for independence from one another using the co- included axial eye length (IOL Master; Carl Zeiss Meditec, linearity diagnostic methods of condition indices and vari- Dublin, California, USA), as well as corneal curvature ance inflation factors. (mean simulated K values) and central corneal thickness The variables were tested in 2 groups: specifically, all using rotating Scheimpflug tomography (Pentacam; variables together and the 16 investigator-derived variables Oculus, Wetzlar, Germany). alone. The final assessment of the matrix indicated that 10 of the variables from the list of 23 exhibited sufficient inde- STATISTICAL ANALYSIS: The estimated sample size pendence from one another (maximum condition index required to detect a 1-unit difference in CH at the 0.05 sig- <10, maximum variance inflation factor <10). The results nificance level was calculated using Minitab based on of a similar analysis for the 16 investigator-derived vari- published standard deviations with 80% power. A group ables indicated that 8 were sufficiently independent to be size of 10 was estimated to be sufficient. Mean and standard included in a multivariable study. deviation values and 2-sample unpaired t tests were calcu- Two separate multivariable models were constructed us- lated for all variables (Minitab v17; Minitab Inc, State Col- ing the 2 separate groups of independent variables. Multi- lege, Pennsylvania, USA). variate backward logistic regression methods were used to To assess the predictive ability of the 23 measurements generate reduced models for both sets of variables. A taken (including the standard and user-derived ORA vari- reduced model is one containing only statistically signifi- ables, as well as geometric measurements), we first calcu- cant variables (P < .05). For both sets of variables, the final

58 AMERICAN JOURNAL OF OPHTHALMOLOGY JANUARY 2016 model reduced to 2 terms. These 2 terms were used to generate an AUROC curve and the resultant curve was TABLE 1. Comparison of Age, Intraocular Pressure, and tested against the various single-variable model AUROC Ocular Geometry in Marfan Syndrome and Control Groups curves to check for improvement in sensitivity and speci- P ficity (SAS v9.3; SAS Institute, Cary, North Carolina, Variable Control Marfan Syndrome Value USA). Number of eyes 24 13 Age 29.5 6 11.7 33.5 6 20.0 .5 IOPcc (mm Hg) 14.9 6 3.3 15.5 6 3.3 .6 IOPg (mm Hg) 15.2 6 3.9 14.1 6 3.1 .4 Central corneal 561.3 6 23.9 552.5 6 42.4 .5 RESULTS thickness (mm) Corneal curvature 42.70 6 1.81 41.25 6 2.09 .046* DEMOGRAPHICS AND CLINICAL FINDINGS IN STUDY PARTIC- (Kmean, diopters) ipants are summarized in Table 1. The 2 diagnostic groups Axial length (mm) 24.04 6 1.31 24.61 6 1.41 .07 were successfully age matched. The 2 study groups were roughly similar ethnically, as both were predominantly IOPcc ¼ corneal-compensated intraocular pressure; IOPg ¼ white. Specifically, the Marfan syndrome group included Goldmann-correlated intraocular pressure. 10 white (77%), 2 African-American (15%), and 1 His- * ¼ statistically significant P value. panic (8%) participants. The control group included 17 white (71%), 4 Asian (17%), 2 Asian/Indian (8%), and 1 African-American (4%) participants. The corneas of indi- 69%, specificity 92%, and positive and negative predictive viduals with Marfan syndrome were significantly flatter values of 82% and 85%, respectively. than those of controls, with Kmean of 41.25 6 2.09 D for Marfan syndrome corneas. There were no significant differ- ences in the other basic measurements collected for the study participants, including corneal-compensated intraoc- DISCUSSION ular pressure, Goldmann-correlated intraocular pressure, central corneal thickness, or axial length. THE CLINICAL DIAGNOSIS OF MARFAN SYNDROME HAS BEEN Ocular Response Analyzer measurements are included in a challenge since its identification by Antoine Marfan over Table 2, including investigator-derived and 2 standard a century ago.3 Without a pathognomonic feature, diag- ORA biomechanical variables (CH, CRF). Six of the 16 nosis relies on an arbitrary combination of diagnostic investigator-derived variables and both standard variables criteria that have evolved as understanding of the disease were significantly different between the 2 groups. These and methods of detection have progressed.2–6 Because of included variables from 3 categories: those derived from the continuing difficulties in making a clinical diagnosis, applanation signal intensity (Group 1: Concavity Min, especially in mild or atypical cases, it is appropriate to Concavity Mean), from pressure measurements (Group 2: consider novel strategies in evaluating the broad-reaching Corneal Resistance Factor, Corneal Hysteresis, P1, P2, impact of fibrillin-1 mutations. To this effect, we used the P1P2Avg), and from the combination of pressure and Ocular Response Analyzer to characterize the corneal defor- applanation signal intensity (Group 5: HLA). mation responses of the Marfan syndrome cornea, and found The AUROC values for all biomechanical and geomet- that alterations in corneal biomechanical behavior can be a ric variables that were found to have significantly better useful tool in the diagnosis of Marfan syndrome. diagnostic capability than by chance are displayed in Use of the ORA to assess differences in corneal biome- Table 3. The Youden index was used to identify cutoff chanical behavior was recently shown by our group to be values for each of these variables with corresponding sensi- an effective means of predicting a diagnosis of keratoco- tivity, specificity, and positive and negative predictive nus.16 Many groups have used this measurement approach values. When assessed individually, the best-performing to characterize ocular disease, either by assessing the stan- variable was Concavity Min (AUROC 0.80, cutoff 51.01, dard ORA variables or through novel variables.23,24 The sensitivity 54%, specificity 96%), an indirect measurement investigator-derived variables considered in the present of corneal bending resistance. study assess specific aspects of the corneal response to air Via backward elimination multivariable logistic regres- puff deformation, monitored through reflection of infrared 16 sion, the combination of corneal curvature (Kmean) and light off the cornea surface. The variables relate to the HLA was found to have greater predictive value for Marfan applanation signal intensity, applied pressure, tissue syndrome than any other individual variable or combina- response time, or these properties in combination. Through tion of variables, with an AUROC value of 0.85. Using measurement of these variables in the Marfan syndrome the regression equation in Table 4, measurement of HLA cornea and controls, we observed several differences that and corneal curvature may be used to generate the proba- shed insight into the probable effects of fibrillin-1 muta- bility of a diagnosis of Marfan syndrome, with sensitivity tions on corneal biomechanical behavior. Specifically,

VOL. 161 CORNEAL DEFORMATION RESPONSE AND GEOMETRY IN MARFAN SYNDROME 59 60

TABLE 2. Definition of Air Puff–Derived Corneal Response Variables and Comparison in Marfan Syndrome and Control Groups

Control Marfan Syndrome

Group Variable Operational Definition Mean 6 SD Mean 6 SD P Value

1: Applanation signal intensity A1 Peak intensity of first applanation event 705 6 89 629 6 146 .1 6 6

A A2 Peak intensity of second applanation event 649 80 567 161 .1

MERICAN Applanation Peak Difference A2 A1 56 6 105 62 6 106 .9 Concavity Min Minimum applanation intensity between A1 and A2 69 6 14 48 6 20 .003* Concavity Mean Mean applanation intensity between A1 and A2 173 6 25 145 6 31 .01* J

UNLOF OURNAL 2: Pressure signal CRF (mm Hg) Corneal resistance factor (P1 0.7P2) 11.0 6 1.7 9.5 6 1.6 .01* CH (mm Hg) Corneal hysteresis (P2 P1) 11.2 6 1.2 9.8 6 1.7 .01* P1 (mm Hg) Pressure at first applanation event 55.6 6 7.2 47.9 6 7.8 .007* P2 (mm Hg) Pressure at second applanation event 44.3 6 6.1 38.1 6 6.3 .008* þ 6 6 O P1P2Avg (mm Hg) (P1 P2)/2 49.9 6.6 43.0 7.0 .008*

PHTHALMOLOGY Pmax (mm Hg) Peak value of pressure signal 488.6 6 40.1 470.6 6 34.1 .2 3: Temporal response variables Concavity Duration (msec) Time lapse between A1 and A2 10.88 6 0.64 10.93 6 0.53 .8 Concavity Time (msec) Time from onset of applied pressure to Concavity Min 13.62 6 3.65 13.34 6 4.48 .9 Lag Time Time between Pmax and Concavity Min 2.58 6 2.75 2.35 6 4.06 .9 4: Applanation intensity and response time Slope Down (msec 1) Negative slope of the first applanation peak, from peak to 7 6 205 71 6 189 .4 inflection point Slope Up (msec 1) Positive slope of the first applanation peak, from inflection point to 84.5 6 31.5 73.6 6 34.4 .4 peak 5: Pressure and applanation intensity HLA Area enclosed by pressure vs applanation function 38 863 6 13 668 26 412 6 15 699 .03* 6: Pressure and time Impulse Area under pressure vs time curve 10 063 6 3228 10 170 6 2812 .9

CH ¼ corneal hysteresis; CRF ¼ corneal resistance factor; HLA ¼ hysteresis loop area. * ¼ statistically significant P value. J NAY2016 ANUARY TABLE 3. Comparison of the Top-Performing Corneal Response Variables and Geometric Measurements for Distinguishing Marfan Syndrome Eyes From Controls

Confidence Group Variable AUROC P Value Interval Cutoff Sensitivity (%) Specificity (%) PPV NPV

Applanation signal Concavity Min 0.80 .008 (0.65, 0.95) 51.01 54 96 88 79 intensity Concavity Mean 0.79 .02 (0.63, 0.95) 163.33 85 67 58 89 Pressure CRF (mm Hg) 0.74 .02 (0.57, 0.92) 10.30 85 63 53 88 CH (mm Hg) 0.77 .01 (0.60, 0.94) 10.90 77 71 59 85 P1 (mm Hg) 0.76 .01 (0.60, 0.93) 51.80 85 67 58 89 P2 (mm Hg) 0.75 .01 (0.58, 0.92) 41.01 85 63 55 88 P1P2Avg (mm Hg) 0.76 .01 (0.59, 0.92) 46.35 85 67 58 89 Pressure and HLA 0.72 .03 (0.54, 0.89) 26 213.84 54 88 70 78 applanation intensity Geometric measurements Corneal curvature (Km, D) 0.72 .04 (0.54, 0.90) 41.40 D 62 79 62 79

AUROC ¼ area under the receiver operating characteristic curve; CH ¼ corneal hysteresis; CRF ¼ corneal resistance factor; D ¼ diopter; HLA ¼ hysteresis loop area; NPV ¼ negative predictive value; PPV ¼ positive predictive value.

with Marfan syndrome, as decreased HLA was found to TABLE 4. Multivariate Regression Equation for Prediction of have a high specificity (88%) for Marfan syndrome. A num- Marfan Syndrome Disease Phenotype Based on ber of variables (Concavity Mean, CRF, P1, P2, and Measurement of Hysteresis Loop Area and Corneal P1P2Avg) had moderately high sensitivity values (all Curvature 85%), which indicates that these variables may be more

Equation AUROC Sensitivity Specificity PPV NPV helpful for Marfan syndrome screening. Furthermore, considering the dynamic variables along ¼ Log(prob/[1 prob]) 0.84 69 92 82 85 with static corneal measurements, we found that the com- 39.35 0.00012* bination of HLA with corneal curvature (K ) may also HLA 0.859*K mean mean predict a diagnosis of Marfan syndrome in up to 85% of in- AUROC ¼ area under the receiver operating characteristic dividuals. Of note, the combination of HLA and corneal curve; HLA ¼ hysteresis loop area; NPV ¼ negative predictive curvature demonstrates greater predictive value than either value; PPV ¼ positive predictive value; prob ¼ the probability variable independently, as each may predict the diagnosis of Marfan syndrome presence. of Marfan syndrome in 72% of patients when considered alone. The combination of Concavity Min and corneal cur- vature was also tested using multivariate analysis; however, lower Concavity Min and Concavity Mean observed in the this combination did not perform better than single- study group indicates greater maximal deformation of the predictor models. A regression equation incorporating Marfan syndrome cornea. Lower P1, P2, and P1P2Avg HLA and corneal curvature is provided in this study and demonstrate a lower amount of air pressure required for may be used in the clinical setting to estimate the probabil- deformation. Additionally, decreased HLA, a comprehen- ity of an individual having Marfan syndrome. Based on this sive measurement of hysteresis described in detail previ- equation we found that decreased values for corneal curva- ously, signifies decreased energy dissipation capacity of ture and/or HLA increase the likelihood of the individual’s the Marfan syndrome cornea.16 In sum, these differences having a diagnosis of Marfan syndrome. indicate that the cornea in Marfan syndrome has decreased A 2008 article published by Rybczynski and associates25 resistance to bending, and may be less capable of dissipating examined the diagnostic power of the 1996 Ghent criteria, energy from the external environment. an analysis that was influential in the 2010 revisions.2 Many of these variables were found to have the capacity These authors defined high diagnostic power as having a to predict a diagnosis of Marfan syndrome, with the best- positive likelihood ratio (LRþ) >10, and found the best- performing single variable being Concavity Min (Concav- performing diagnostic criteria to include facial appearance ity Min 47.5 6 20.0, AUROC 80). The high predictive (LRþ 13.47), ectopia lentis (LRþ 21.08), hypoplastic iris value of Concavity Min along with its high specificity or ciliary muscle (LRþ 12.19), and dural ectasia (96%) indicates that this measurement could have a role (19.78).25 Dilation of the ascending aorta, a cardinal as a confirmatory test in the evaluation of a patient with feature of Marfan syndrome, had a slightly lower positive a suspected diagnosis of Marfan syndrome. HLA could likelihood ratio of 6.35.25 Additional ocular features exam- additionally be useful for helping to identify individuals ined included flat cornea (LRþ 5.22) and increased axial

VOL. 161 CORNEAL DEFORMATION RESPONSE AND GEOMETRY IN MARFAN SYNDROME 61 length of globe (LRþ 1.64). Myopia >3 D was not in axial eye length (which further supports the strength assessed.25 In the present study, we can calculate that Con- of corneal biomechanical properties in distinguishing cavity Min has a positive likelihood ratio of 12.9 (account- Marfan syndrome). It is also possible that only a small ing for significant digits). This helps to contextualize the portion of individuals with Marfan syndrome have high diagnostic power of Concavity Min relative to the pre- markedly longer eyes, and that the majority of individuals viously established criteria, suggesting it may be as strong with Marfan syndrome have eyes of length within the as, if not stronger than, many of the criteria currently normal range. This is supported by clinical observation, used. It would be valuable to assess the positive likelihood as well as in a previous study that found the distribution ratios in a larger study in which all candidate variables are of axial eye length in Marfan syndrome to be positively measured to allow direct comparison. In the present study skewed.28 we cannot directly compare corneal deformation responses A previous study carried out by Kara and associates used such as Concavity Min to the systemic criteria of the study the standard ORA variables to retrospectively assess the participants, as assessment of systemic features was not biomechanical behavior of the Marfan syndrome cornea.22 performed systematically on every individual prior to study These authors found that corneal hysteresis, corneal resis- entry, and there are insufficient data for a powered analysis. tance factor, and Goldmann-correlated intraocular pres- The importance of Concavity Min as a putative diagnostic sure were significantly lower in Marfan syndrome eyes is further supported by the fact that it outperformed corneal with ectopia lentis in comparison to Marfan syndrome curvature in predicting a diagnosis of Marfan syndrome in eyes without ectopia lentis; however, they did not find a dif- the present study (AUROC for Concavity Min 0.80 and ference between the Marfan syndrome eyes and controls. corneal curvature 0.72). Decreased corneal curvature has The disparity between results might be explained by differ- been observed as an ocular feature of Marfan syndrome in ences in the participant demographics (the study by Kara many previous studies18–21 and was included as a minor and associates was carried out in Istanbul, Turkey) or diagnostic criterion in both the Berlin and 1996 Ghent possibly due to a difference in the participant age, as the criteria.5,6 The greater diagnostic power of Concavity participants of their study were somewhat younger than Min relative to corneal curvature in this study, as well as in the current analysis, especially in view of the progressive the relatively high diagnostic performance of Concavity worsening of the manifestations of Marfan syndrome with Min in comparison to the previous assessment of systemic age.7 However, the most likely explanation is that the pre- criteria by Rybczynski and associates, strongly supports sent study used custom variables shown to be more sensitive consideration of corneal biomechanical behavior in for discriminating disease-related biomechanical differ- future Marfan syndrome diagnostic schemes. ences in other corneal conditions.16 It is important to note that the mechanisms underlying The differences observed in corneal deformation re- corneal curvature differences in Marfan syndrome are not sponses between Marfan syndrome and control corneas is known. It is possible that the fibrillin-1-related changes likely reflective of the global impact of aberrant fibrillin-1 in the Marfan syndrome eye might reflect generalized alter- microfibrils on the eye in general. Fibrillin-1 is expressed ations in the whole eye, in contrast to the focal corneal nearly ubiquitously in the eye and is a known component weakening that is postulated to lead to corneal steepening of the Bowman layer, the basement membrane of the in keratoconus.26 Detection of similar changes in the vari- corneal epithelium, which is the most anterior layer of ables measured by the ORA does not imply similar mech- the cornea.9 The architecture of the anterior-most 120 mi- anisms of disease, but rather reflects a whole-eye response crometers of the cornea has been shown to be responsible to the air puff, which can be influenced by extracorneal for corneal stability.29 As differences in both quantity structures.27 and quality of microfibrils in the Marfan syndrome eye While the nature of the Marfan syndrome cornea as be- have been observed histologically, it is reasonable to postu- ing significantly flatter is well supported, there are conflict- late that anomalous fibrillin-1 in the Bowman layer could ing data in the literature regarding central corneal influence corneal biomechanical behavior, as was observed thickness. In this study we did not find a significant differ- here.10,11,29 ence in corneal thickness between the Marfan syndrome A stated goal of the 2010 Ghent criteria was to empha- and control groups. This finding, in conjunction with a size simplicity while maintaining accuracy in diagnosis of lack of measured difference in intraocular pressure between Marfan syndrome.2 Incorporating measurement of corneal the 2 groups, makes these factors unlikely to impact corneal deformation responses and corneal curvature in the biomechanical behavior as measured by the ORA. With re- ophthalmologic evaluation of Marfan syndrome could be gard to axial eye length, several previous studies have found a next feasible step in the evolution of the Marfan syn- the Marfan syndrome eye to be longer.18,21,28 In the present drome clinical diagnostic criteria, improving detection study, there was a nonsignificant trend toward longer eyes while maintaining low invasiveness. Currently, evaluation in Marfan syndrome (P value ¼ .07), which is in of the ocular features of Marfan syndrome requires a slit- agreement with prior studies. It is possible that we had lamp examination with a fully dilated pupil, assessing for insufficient study power to detect a significant difference sometimes subtle displacement of the lens and qualitative

62 AMERICAN JOURNAL OF OPHTHALMOLOGY JANUARY 2016 abnormalities of the zonule fibers. The examination should study, 4 measurements were taken of the right eye, and be performed by an ophthalmologist who is trained to the measurement with the highest waveform score (or detect minor lens displacements. Also, the pupil in Marfan best score value, the instrument’s internal measurement syndrome has been observed to dilate slowly or insuffi- of reliability) was included in statistical analysis. Finally, ciently,6 which can present a practical difficulty in the clin- the analysis of significance performed here intrinsically ical assessment of the position of the lens. Measurement of accounts for variance, as a significant result implies a corneal deformation responses and corneal curvature are mean difference that surpasses the variance of the mea- obtained using noncontact devices, can be performed by surement. a trained technician, and do not require pupillary dilation. This study paves the way for continued investigation This presents a significant diagnostic advantage in assessing into the potential for corneal biomechanical behavior to corneal deformation responses and corneal curvature. aid in the diagnosis of Marfan syndrome. Since completion We acknowledge that the current study has a small sam- of this study, the Corvis ST was released by Oculus, which ple size. However, a priori sample size calculations and the directly images deformation of a corneal optical section us- final statistical analysis suggest that the sample sizes ob- ing a high-speed Scheimpflug camera. Application of tained were sufficient to detect a meaningful difference, similar analyses for assessing subtle alterations in corneal and the results support the case for continued investiga- deformation responses to emerging technologies such as tion of corneal biomechanical behavior as an aid in the the Corvis ST may enhance our understanding of the diagnosis of Marfan syndrome. With regard to variance, biomechanical impact of aberrant fibrillin-1 on the cornea our previous studies using the ORA in a variety of patient and lead to continued refinement of our evolving strategies populations demonstrated low levels of variance. In for diagnosing Marfan syndrome. patients with keratoconus, the portion of variance While ectopia lentis is a cardinal feature of Marfan syn- explained by IOP ranged from 5% to 16% for the top 5 drome, an estimated 40% of individuals with Marfan syn- disease-predicting variables (8% for Concavity min).16 drome do not have subluxated lenses.18 A future goal of In individuals who underwent myopic LASIK and photo- our team is to determine the ability of these ORA refractive keratectomy, the variance in biomechanical investigator-derived variables to correctly predict a diag- changes by the most strongly correlating variables was nosis of Marfan syndrome in individuals who do not have less than 11%.30 Regarding potential fluctuation among ectopia lentis, and thus pose a greater diagnostic challenge. examiners, nearly all of the ORA measurements in this We also intend to investigate the relationship between study were performed by the same person. However, based altered corneal biomechanical behavior and the systemic on clinical experience, we have not observed noticeable features of Marfan syndrome. By seeking out unique, fluctuation in ORA measurements by different examiners. low-risk means to diagnose Marfan syndrome in those indi- A previous study carried out by Sullivan-Mee and associ- viduals with a more subtle phenotype, and recognizing pat- ates showed reproducibility of the standard ORA mea- terns in ocular and systemic features, we hope to improve surements between different examiners.31 In the present the ability to effectively diagnose this condition.

FUNDING/SUPPORT: THIS WORK WAS SUPPORTED IN PART BY NEI R01 EY023381 (W.J.D.; BETHESDA, MARYLAND), A Career Starter Grant from the Knights Templar Eye Foundation (L.C.B.; Flower Mound, Texas), a Summer Student Fellowship from Fight for Sight (L.C.B.; New York, New York), and an Unrestricted Grant from Research to Prevent Blindness to the Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (New York, New York). Financial disclosures: William J. Dupps, Jr is a consultant for Ziemer (Port, Switzerland), a medical advisory board member and recipient of sponsored research support from Avedro (Waltham, Massachusetts), and a recipient of sponsored research support from Zeiss (Oberkochen, Germany). William J. Dupps, Jr and Matthew R. Ford are inventors listed on intellectual property filed through Cleveland Clinic Innovations/OptoQuest (Cleveland, Ohio). Ibrahim Seven is a consultant for OptoQuest. The following authors have no financial disclosures: Lauren C. Beene, Elias I. Traboulsi, Abhijit Sinha Roy, and Robert S. Butler. All authors attest that they meet the current ICMJE criteria for authorship. Special thanks to Dr Rocio Moran (past Cleveland Clinic Foundation, current MetroHealth System, both in Cleveland, Ohio), Dr Anna Mitchell (University Hospitals Case Medical Center, Cleveland, Ohio), and Meghan Marino (Cole Eye Institute, Cleveland, Ohio).

REFERENCES elongation of the bones with some degree of thinning.]. Bull Memoires Socie´te´ Medicale Hoˆspitaux Paris 1896;13:220–226. 1. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome 4. McKusick V. The cardiovascular aspects of Marfan’s syndrome caused by a recurrent de novo missense mutation in the fibril- 1955;11(3):321–342. lin gene. Nature 1991;352(6333):337–339. 5. Beighton P, de Paepe A, Danks D, et al. International 2. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology of heritable disorders of connective tissue, Berlin, nosology for the Marfan syndrome. J Med Genet 2010;47(7): 1986. Am J Med Genet 1988;29(3):581–594. 476–485. 6. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, 3. Marfan AB. [A case of congenital deformation of the four Pyeritz RE. Revised diagnostic criteria for the Marfan syn- limbs, more pronounced at the extremities, characterized by drome. Am J Med Genet 1996;62(4):417–426.

VOL. 161 CORNEAL DEFORMATION RESPONSE AND GEOMETRY IN MARFAN SYNDROME 63 7. Summers KM, West JA, Peterson MM, Stark D, McGill JJ, 20. Heur M, Costin B, Crowe S, et al. The value of keratometry West MJ. Challenges in the diagnosis of Marfan syndrome. and central corneal thickness measurements in the clinical Med J Aust 2006;184(12):627–631. diagnosis of Marfan syndrome. Am J Ophthalmol 2008; 8. Ramirez F, Dietz HC. Marfan syndrome: from molecular path- 145(6):997–1001. ogenesis to clinical treatment. Curr Opin Genet Dev 2007; 21. Drolsum L, Rand-Hendriksen S, Paus B, Geiran OR, 17(3):252–258. Semb SO. Ocular findings in 87 adults with Ghent-1 verified 9. Wheatley HM, Traboulsi EI, Flowers BE, et al. Immunohisto- Marfan syndrome. Acta Ophthalmol (Copenh) 2015;93(1): chemical localization of fibrillin in human ocular tissues. 46–53. Relevance to the Marfan syndrome. Arch Ophthalmol 1995; 22. Kara N, Bozkurt E, Baz O, et al. Corneal biomechanical 113(1):103–109. properties and intraocular pressure measurement in 10. Traboulsi EI, Whittum-Hudson JA, Mir SH, Maumenee IH. Marfan patients. J Cataract Refract Surg 2012;38(2): Microfibril abnormalities of the lens capsule in patients 309–314. with Marfan syndrome and ectopia lentis. Ophthalmic Genet 23. Kerautret J, Colin J, Touboul D, Roberts C. Biomechanical 2000;21(1):9–15. characteristics of the ectatic cornea. J Cataract Refract Surg 11. Mir S, Wheatley HM, Hussels IE, Whittum-Hudson JA, 2008;34(3):510–513. Traboulsi EI. A comparative histologic study of the fibrillin 24. Mikielewicz M, Kotliar K, Barraquer RI, Michael R. Air-pulse microfibrillar system in the lens capsule of normal subjects corneal applanation signal curve parameters for the charac- and subjects with Marfan syndrome. Invest Ophthalmol Vis terisation of keratoconus. Br J Ophthalmol 2011;95(6): Sci 1998;39(1):84–93. 793–798. 12. Luce DA. Determining in vivo biomechanical properties of 25. Rybczynski M, Bernhardt AMJ, Rehder U, et al. The spec- the cornea with an ocular response analyzer. J Cataract Refract trum of syndromes and manifestations in individuals screened Surg 2005;31(1):156–162. for suspected Marfan syndrome. Am J Med Genet A 2008; 13. Kirwan C, O’Keefe M. Corneal hysteresis using the Reichert 146A(24):3157–3166. ocular response analyser: findings pre- and post-LASIK and 26. Roberts CJ, Dupps WJ Jr. Biomechanics of corneal ectasia and LASEK. Acta Ophthalmol (Copenh) 2008;86(2):215–218. biomechanical treatments. J Cataract Refract Surg 2014;40(6): 14. Shah S, Laiquzzaman M, Bhojwani R, Mantry S, Cunliffe I. 991–998. Assessment of the biomechanical properties of the cornea 27. Kling S, Marcos S. Contributing factors to corneal deforma- with the ocular response analyzer in normal and keratoconic tion in air puff measurements. Invest Ophthalmol Vis Sci eyes. Invest Ophthalmol Vis Sci 2007;48(7):3026–3031. 2013;54(7):5078–5085. 15. Fontes BM, Ambro´sio R Jr, Velarde GC, Nose´ W. Corneal 28. Konradsen TR, Zetterstro¨m C. A descriptive study of ocular biomechanical evaluation in healthy thin corneas compared characteristics in Marfan syndrome. Acta Ophthalmol with matched keratoconus cases. Arq Bras Oftalmol 2011; (Copenh) 2013;91(8):751–755. 74(1):13–16. 29. Mu¨ller LJ, Pels E, Vrensen GF. The specific architecture of 16. Hallahan KM, Sinha Roy A, Ambrosio R, Salomao M, the anterior stroma accounts for maintenance of corneal cur- Dupps WJ. Discriminant value of custom ocular response vature. Br J Ophthalmol 2001;85(4):437–443. analyzer waveform derivatives in keratoconus. Ophthalmology 30. Santhiago MR, Wilson SE, Hallahan KM, et al. Changes 2014;121(2):459–468. in custom biomechanical variables after femtosecond 17. Iordanidou V, Sultan G, Boileau C, Raphael M, Baudouin C, laser in situ keratomileusis and photorefractive keratec- Marfan Study Group. In vivo corneal confocal microscopy in tomy for myopia. J Cataract Refract Surg 2014;40(6): Marfan syndrome. Cornea 2007;26(7):787–792. 918–928. 18. Maumenee IH. The eye in the Marfan syndrome. Trans Am 31. Sullivan-Mee M, Gerhardt G, Halverson KD, Qualls C. Ophthalmol Soc 1981;79:684–733. Repeatability and reproducibility for intraocular pressure 19. Sultan G, Baudouin C, Auzerie O, et al. Cornea in Marfan measurement by dynamic contour, ocular response analyzer, disease: Orbscan and in vivo confocal microscopy analysis. and goldmann applanation tonometry. J Glaucoma 2009; Invest Ophthalmol Vis Sci 2002;43(6):1757–1764. 18(9):666–673.

64 AMERICAN JOURNAL OF OPHTHALMOLOGY JANUARY 2016 Biosketch

Lauren C. Beene is a first year resident in at Rainbow Babies & Children’s Hospital, University Hospitals Case Medical Center in Cleveland, Ohio. She is very grateful for the opportunities she had to learn and grow while carrying out this research project as a medical student under the mentorship of Dr. Elias Traboulsi and Dr. William J. Dupps.

VOL. 161 CORNEAL DEFORMATION RESPONSE AND GEOMETRY IN MARFAN SYNDROME 64.e1